Skip to main content

Table 1 Clinical characteristics of DLBCL patients

From: Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape

Clinical characteristics

DLBCL patients

Healthy donors

Median age (range), years

56 (28–84)

55(28–80)

 Male, n

25

25

 Female, n

20

20

Lactate dehydrogenase level

  

 Normal

31

Null

 Elevated

14

Null

Ann Arbor Stage

  

 I–II

13

Null

 III–IV

32

Null

Cell of origin

  

 GCB

26

Null

 Non-GCB

19

Null

IPI

  

 0–2

26

Null

 3–5

19

Null

Location

  

 Nodal

16

Null

 Extranodal

29

Null

B symptom

  

 Yes

13

Null

 No

32

Null

  1. DLBCL diffuse large B-cell lymphoma, GCB germinal center B-celllike, IPI international prognostic index